Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Jilaihawi, R. Makkar, Mohammad Kashif, K. Okuyama, T. Chakravarty, T. Shiota, G. Friede, M. Nakamura, Niraj Doctor, A. Rafique, Kentaro Shibayama, Hirotsugu Mihara, A. Trento, W. Cheng, J. Friedman, D. Berman, G. Fontana (2014)
A revised methodology for aortic-valvar complex calcium quantification for transcatheter aortic valve implantation.European heart journal cardiovascular Imaging, 15 12
PF Ludman, N Moat, MA Belder, DJ Blackman, A Duncan, W Banya, PA MacCarthy, D Cunningham, O Wendler, D Marlee, D Hildick-Smith, CP Young, J Kovac, NG Uren, T Spyt, U Trivedi, J Howell, H Gray (2015)
UK TAVI steering committee and the national institute for cardiovascular outcomes research. Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK transcatheter aortic valve implantation (TAVI) registry 2007 to 2012Circulation, 131
Karl Isaaz, Luisa Munoz, T. Ports, Nelson Schiller (1991)
Demonstration of postvalvuloplasty hemodynamic improvement in aortic stenosis based on Doppler measurement of valvular resistance.Journal of the American College of Cardiology, 18 7
H. Baumgartner, V. Falk, Jeroen Bax, M. Bonis, C. Hamm, Per Holm, B. Iung, P. Lancellotti, E. Lansac, Daniel Muñoz, R. Rosenhek, J. Sjögren, P. Mas, A. Vahanian, T. Walther, O. Wendler, S. Windecker, J. Zamorano (2017)
2017 ESC/EACTS Guidelines for the management of valvular heart disease.European heart journal, 38 36
AP Kappetein, SJ Head, P Généreux, N Piazza, NM Mieghem, EH Blackstone, TG Brott, DJ Cohen, DE Cutlip, GA Es, RT Hahn, AJ Kirtane, MW Krucoff, S Kodali, MJ Mack, R Mehran, J Rodés-Cabau, P Vranckx, JG Webb, S Windecker, PW Serruys, MB Leon (2012)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus documentJ Am Coll Cardiol, 60
A. Finkelstein, A. Steinvil, Z. Rozenbaum, A. Halkin, S. Banai, I. Barbash, V. Guetta, A. Segev, H. Danenberg, K. Orvin, H. Assa, Abid Assali, R. Kornowski (2018)
Efficacy and safety of new-generation transcatheter aortic valves: insights from the Israeli transcatheter aortic valve replacement registryClinical Research in Cardiology, 108
R. Zahn, N. Werner, U. Gerckens, A. Linke, H. Sievert, P. Kahlert, R. Hambrecht, S. Sack, M. Abdel-Wahab, E. Hoffmann, U. Zeymer, S. Schneider (2017)
Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosisHeart, 103
Won-Keun Kim, J. Blumenstein, C. Liebetrau, A. Rolf, L. Gaede, A. Linden, M. Arsalan, M. Doss, J. Tijssen, C. Hamm, T. Walther, H. Möllmann (2017)
Comparison of outcomes using balloon-expandable versus self-expanding transcatheter prostheses according to the extent of aortic valve calcificationClinical Research in Cardiology, 106
M. Leon, Craig Smith, M. Mack, M. Mack, R. Makkar, L. Svensson, S. Kodali, V. Thourani, M. Tuzcu, D. Miller, H. Herrmann, Darshan Doshi, D. Cohen, A. Pichard, S. Kapadia, T. Dewey, V. Babaliaros, W. Szeto, Mathew Williams, D. Kereiakes, A. Zajarías, K. Greason, B. Whisenant, R. Hodson, J. Moses, A. Trento, David Brown, W. Fearon, P. Pibarot, R. Hahn, W. Jaber, W. Anderson, Maria Alu, J. Webb (2016)
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.The New England journal of medicine, 374 17
A. Kappetein, S. Head, P. Généreux, N. Piazza, N. Mieghem, Eugene Blackstone, T. Brott, David Cohen, D. Cutlip, G. Es, R. Hahn, Ajay Kirtane, Mitchell Krucoff, S. Kodali, Michael Mack, R. Mehran, J. Rodés‐Cabau, P. Vranckx, John Webb, S. Windecker, P. Serruys, Martin Leon (2012)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.European heart journal, 33 19
G. Morgan-Hughes, P. Owens, C. Roobottom, A. Marshall (2003)
Three dimensional volume quantification of aortic valve calcification using multislice computed tomographyHeart, 89
T. Feldman, M. Reardon, V. Rajagopal, R. Makkar, T. Bajwa, N. Kleiman, A. Linke, D. Kereiakes, R. Waksman, V. Thourani, R. Stoler, G. Mishkel, D. Rizik, V. Iyer, T. Gleason, D. Tchétché, J. Rovin, M. Buchbinder, I. Meredith, Matthias Götberg, H. Bjursten, C. Meduri, M. Salinger, D. Allocco, K. Dawkins (2018)
Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical TrialJAMA, 319
P. Casale, I. Palacios, V. Abascal, L. Harrell, R. Davidoff, A. Weyman, M. Fifer (1992)
Effects of dobutamine on Gorlin and continuity equation valve areas and valve resistance in valvular aortic stenosis.The American journal of cardiology, 70 13
J. Caro (2012)
ESC/EACTS Guidelines on the management of valvular heart disease
A. Kappetein, S. Head, P. Généreux, N. Piazza, N. Mieghem, Eugene Blackstone, T. Brott, David Cohen, D. Cutlip, G. Es, R. Hahn, Ajay Kirtane, Mitchell Krucoff, S. Kodali, Michael Mack, R. Mehran, J. Rodés‐Cabau, P. Vranckx, John Webb, S. Windecker, P. Serruys, Martin Leon (2012)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.The Journal of thoracic and cardiovascular surgery, 145 1
R. Binder, S. Stortecky, D. Heg, D. Tueller, R. Jeger, S. Toggweiler, G. Pedrazzini, F. Amann, E. Ferrari, S. Noble, F. Nietlispach, F. Maisano, L. Räber, M. Roffi, J. Grünenfelder, P. Jüni, C. Huber, S. Windecker, P. Wenaweser (2015)
Procedural Results and Clinical Outcomes of Transcatheter Aortic Valve Implantation in Switzerland: An Observational Cohort Study of Sapien 3 Versus Sapien XT Transcatheter Heart ValvesCirculation: Cardiovascular Interventions, 8
P. Ludman, N. Moat, M. Belder, D. Blackman, A. Duncan, W. Banya, P. MacCarthy, D. Cunningham, O. Wendler, Damian Marlee, D. Hildick-Smith, C. Young, J. Kovac, N. Uren, T. Spyt, U. Trivedi, J. Howell, H. Gray (2015)
Transcatheter Aortic Valve Implantation in the United KingdomCLINICAL PERSPECTIVECirculation, 131
(2015)
Clinical Research in Cardiology
H. Baumgartner, J. Hung, J. Bermejo, J. Chambers, T. Edvardsen, S. Goldstein, P. Lancellotti, M. Lefevre, F. Miller, C. Otto (2017)
Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography.European heart journal cardiovascular Imaging, 18 3
S. Kodali, Mathew Williams, Craig Smith, L. Svensson, J. Webb, R. Makkar, G. Fontana, T. Dewey, V. Thourani, A. Pichard, M. Fischbein, W. Szeto, Scott Lim, K. Greason, P. Teirstein, S. Malaisrie, P. Douglas, R. Hahn, B. Whisenant, A. Zajarías, Duolao Wang, J. Akin, W. Anderson, M. Leon, T. Investigators (2012)
Two-year outcomes after transcatheter or surgical aortic-valve replacement.The New England journal of medicine, 366 18
M. Reardon, N. Mieghem, J. Popma, N. Kleiman, L. Søndergaard, Mubashir Mumtaz, David Adams, G. Deeb, Brijeshwar Maini, H. Gada, S. Chetcuti, T. Gleason, J. Heiser, R. Lange, William Merhi, J. Oh, P. Olsen, N. Piazza, Mathew Williams, S. Windecker, S. Yakubov, E. Grube, R. Makkar, Joon Lee, J. Conte, E. Vang, H. Nguyen, Yanping Chang, Andrew Mugglin, P. Serruys, A. Kappetein (2017)
Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk PatientsThe New England Journal of Medicine, 376
W. Bocksch, B. Grossmann, T. Geisler, M. Steeg, M. Droppa, R. Jorbenadze, M. Haap, M. Gawaz, S. Fateh‐Moghadam (2016)
Clinical outcome and paravalvular leakage of the new balloon‐expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacementCatheterization and Cardiovascular Interventions, 88
A. Franzone, C. O'Sullivan, S. Stortecky, D. Heg, J. Lanz, René Vollenbroich, F. Praz, R. Piccolo, M. Asami, Eva Roost, L. Räber, M. Valgimigli, S. Windecker, T. Pilgrim (2017)
Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 12 18
S. Little, J. Oh, L. Gillam, P. Sengupta, D. Orsinelli, J. Cavalcante, J. Chang, D. Adams, G. Zorn, A. Pollak, Sahar Abdelmoneim, M. Reardon, Hongyan Qiao, J. Popma (2016)
Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk PredictionCirculation: Cardiovascular Interventions, 9
S. Kodali, V. Thourani, Jonathon White, S. Malaisrie, Scott Lim, K. Greason, Mathew Williams, M. Guerrero, A. Eisenhauer, S. Kapadia, D. Kereiakes, H. Herrmann, V. Babaliaros, W. Szeto, R. Hahn, P. Pibarot, N. Weissman, J. Leipsic, P. Blanke, B. Whisenant, R. Suri, R. Makkar, G. Ayele, L. Svensson, J. Webb, M. Mack, Craig Smith, M. Leon (2016)
Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis.European heart journal, 37 28
Jeremey Cannon, M. Zile, F. Crawford, B. Carabello (1992)
Aortic valve resistance as an adjunct to the Gorlin formula in assessing the severity of aortic stenosis in symptomatic patients.Journal of the American College of Cardiology, 20 7
H Baumgartner, J Hung, J Bermejo, JB Chambers, T Edvardsen, S Goldstein, P Lancellotti, M LeFevre, F Miller, CM Otto (2017)
Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of EchocardiographyJ Am Soc Echocardiogr, 30
P. Wenaweser, T. Pilgrim, A. Kadner, C. Huber, S. Stortecky, L. Buellesfeld, A. Khattab, Fabienne Meuli, N. Roth, B. Eberle, G. Erdös, H. Brinks, B. Kalesan, B. Meier, P. Jüni, T. Carrel, S. Windecker (2011)
Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality.Journal of the American College of Cardiology, 58 21
M. Seiffert, B. Fujita, M. Avanesov, C. Lunau, G. Schön, L. Conradi, E. Prashovikj, S. Scholtz, J. Börgermann, W. Scholtz, U. Schäfer, G. Lund, S. Ensminger, H. Treede (2016)
Device landing zone calcification and its impact on residual regurgitation after transcatheter aortic valve implantation with different devices.European heart journal cardiovascular Imaging, 17 5
T. Feldman, L. Ford, Y. Chiu, J. Carroll (1992)
Changes in valvular resistance, power dissipation and myocardial reserve with aortic valvuloplasty.The Journal of heart valve disease, 1 1
V. Falk, J. Wöhrle, D. Hildick-Smith, S. Bleiziffer, D. Blackman, M. Abdel-Wahab, U. Gerckens, A. Linke, H. Ince, P. Wenaweser, D. Allocco, K. Dawkins, N. Mieghem (2017)
Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND StudyEuropean Heart Journal, 38
E. Belle, F. Juthier, S. Susen, A. Vincentelli, B. Iung, J. Dallongeville, H. Eltchaninoff, M. Laskar, P. Leprince, M. Lièvre, C. Banfi, J. Auffray, C. Delhaye, P. Donzeau‐Gouge, K. Chevreul, J. Fajadet, A. Leguerrier, A. Prat, M. Gilard, E. Teiger (2014)
Postprocedural Aortic Regurgitation in Balloon-Expandable and Self-Expandable Transcatheter Aortic Valve Replacement Procedures: Analysis of Predictors and Impact on Long-Term Mortality Insights From the FRANCE2 RegistryCirculation, 129
Background The impact of aortic valvular resistance (VR) on the degree of post-transcatheter aortic valve replacement (TAVR) aortic regurgitation (AR) remains unclear. The objective of the study was to investigate the relationship between VR and paravalvular AR after TAVR. Methods Between August 2007 and December 2015, 708 TAVR patients had sufficient data to calculate VR before the intervention and were eligible for the present analysis. The patient population was dichotomized according to VR. The association between VR and post-TAVR AR was separately assessed by prosthesis type. Results Among patients with low VR (LVR; < 238 dynes/cm ), 176 (49.7%) patients were treated with balloon-expand- able (BE) valves and 178 (51.3%) patients with self-expandable (SE) transcatheter valves. Among patients with high VR (HVR ≥ 238), 147 (41.5%) and 207 (68.5%) patients received BE and SE, respectively. Baseline characteristics were similar in both groups irrespective of the type of valve. Patients with HVR had a 2.5-fold risk of ≥ moderate post-TAVR AR com- pared to patients with LVR. Both, HVR (HR 2.45, 95% CI 1.33–4.51) and the use of SE (HR 3.11, 95% CI 1.66–5.82), adj adj emerged as independent predictors of ≥ moderate post-TAVR AR. Moderate or greater post-AR was
Zeitschrift für Kardiologie – Springer Journals
Published: Mar 30, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.